在患有帕金森病的患者中发现了一种新的α-synuclein K58N误解变体
Mohammed Al-Azzani1, Sandrina Weber2, Nagendran Ramalingam3
1University Medical Center Göttingen, Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.
medRxiv : the preprint server for health sciences
|February 24, 2025
概括
一种新的SNCA基因突变,K58N,与帕金森病 (PD) 有关. 这种突变破坏了α-synuclein (aSyn) 功能,影响其结构,膜结合和聚合,为PD病理生物学提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 编码alpha-synuclein (aSyn) 的SNCA基因中的突变和乘法与家族性帕金森病 (PD) 有关.
- 了解PD的分子基础对于开发有效治疗方法至关重要.
研究的目的:
- 确定和描述与帕金森病相关的新型SNCA基因突变.
- 为了研究在α-synuclein中发现的K58N突变的分子和细胞效应.
主要方法:
- 整个外基因组测序被用来识别新的SNCA突变 (NM_000345.4,cDNA 174G>C;蛋白质K58N).
- 进行了生物物理研究和细胞分析,以评估K58N突变对aSyn行为的影响.
主要成果:
- 在患有早期散发性PD的患者中发现了K58N突变.
- K58N aSyn表现出改变的结构,减少了膜结合,增强了体外聚合,改变了细胞分布.
- 这种突变导致每个细胞的含有量较少,凝聚物形成受损,对胺-129酸化的影响最小.
结论:
- 新的K58N SNCA突变为帕金森病的α-synuclein病理生物学提供了新的见解.
- 这一发现有助于理解PD病原体背后的多样化机制.
- 对K58N aSyn的进一步研究可能会揭示帕金森病的治疗点.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.2K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
